Analytical methods in both fish early life stage (ELS) tests

Instrumental HPLC-MS/MS setup
Autosampler: CTC PAL; injection volume: 2 μL; pump: high pressure gradient with 2 Shimadzu LC-10AD pumps and a Shimadzu SCL System Controller; column: Inertsil ODS-3 (GL Sciences 
Validation of HPLC-MS/MS method
Specificity: The biological control samples and an analyzed analytical blank (test water) did not affect the chromatogram at the retention time of diclofenac (DCF). The calibration solutions contained a peak specific for DCF, whose area changed accordingly with known concentration.
Linearity:
The R² fits of the calibration curves used were 0.9995 to 0.9998. This reflects the linearity of the analytical system within the total calibration range of 1.22 to 30.2 µg DCF/L.
Accuracy (recovery) and precision:
Concurrent with the sample analysis, a set of recovery samples accurately fortified at relevant concentrations of DCF was prepared and analyzed. The average recoveries were found to be between 104% and 108% of the spiked values with relative standard deviations between 1.5% and 3.4%. The test sample results were not corrected for recovery. The limit of quantification (LOQ) for DCF in the test and control samples was derived from the lowest calibration solution, which fits into the calibration curve. Taking into account a sample preparation factor of 1.4, the LOQ was 1.71 µg DCF/L (zebrafish test) and approximately 2 µg DCF/L (trout test).
Validation of HPLC/UV method
Linearity: The R² fits of the calibration curves used were between 0.9990 and 1.000. This reflects the linearity of the analytical system within the total calibration range of 43.4 to 10700 µg/L.
Accuracy (recovery) and precision:
Concurrent with the sample analysis, a set of recovery samples accurately fortified at relevant concentrations of DCF was prepared and analyzed. The average recoveries were found to be between 83% and 112% of the spiked values with relative standard deviations between 0.5% and 9.9%. The test sample results were not corrected for recovery.
Calculation of the analytical results
From the calibration curve, the concentration x of the test substance in an injected sample was 
Analytical methods in the fish bioconcentration (BCF) test
Instrumental setup for total radioactivity
Liquid scintillation counters Packard TRI-CARB 2500 TR and 2900 TR equipped with DPM and luminescence options.
All measurements were performed after scintillation background correction and all samples were determined at least in duplicate. The following scintillation fluids and reagents were used: A IrgaSafe Plus (PerkinElmer), B Solvable (PerkinElmer). Aqueous samples: tank water samples (10 mL) were mixed with 10 mL of scintillation fluid A before measurement. Fish samples:
solubilized fish samples of 1.0 mL (containing 100 mg tissue) were measured in 10 mL scintillation fluid A. 
Lipid measurement in fish
The fish pools were homogenized in a Waring Blendor in the presence of dry-ice, and the homogenized tissue samples were dried with Hydromatrix drying reagent. Thereafter, the homogenates were extracted in two cycles in the ASE (Accelerated Solvent Extraction) system using hexane. The hexane solvent extracts were evaporated under as gentle steam of nitrogen.
The lipid pellets were dried at 105°C to a constant weight.
Calculation of BCF's
The steady state BCF SS is the ratio of the concentration in fish (C f ) at the plateau level (i.e. at the last three successive fish sampling dates) to the measured concentration in water (C w ). The kinetic bioconcentration factor (BCF K ) was calculated by fitting the uptake rate constant k 1 and the depuration rate constant k 2 by the non-linear parameter estimation program Origin 
Histopathological evaluation in the ELS test with rainbow trout
Twenty fish (five per tank replicate) from each test concentration and from the control were randomly selected for histopathological examination of the liver, kidney and gills at the end of the exposure period. These organs were examined for any lesion or alteration.
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Biological results in the ELS tests
